BioSpace News Archive

Business

CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody

Crown Bioscience and a global drug discovery and development services company announced a strategic licensing agreement with CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company.

March 23, 2018
·
3 min read
Policy

Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma

Cabozantinib is the first and only monotherapy to demonstrate superior clinical efficacy over sunitinib in treatment-naïve patients with intermediate- or poor-risk aRCC.

March 23, 2018
·
13 min read
FDA

Canon Medical Systems’ Premium Ultrasound Provides New and Unique Features for a Wide Range of Liver Analysis

Industry’s Most Comprehensive Liver Analysis Suite with Attenuation Imaging and Shear Wave Dispersion

March 23, 2018
·
3 min read
Pharm Country

Anticancer Agent LENVIMA® Approved for Additional Indication of Unresectable Hepatocellular Carcinoma in Japan, First Approval Worldwide for LENVIMA for HCC

First New Front-Line Treatment Option for HCC Approved in Japan in Nearly 10 Years

March 23, 2018
·
40 min read
Business

Can-Fite Reports 2017 Financial Results & Provides Clinical Update

A multi-million dollar agreement has been signed with Gebro Holdings for the distribution of Piclidenoson in 3 European Countries

March 23, 2018
·
14 min read
Business

Nuvo Pharmaceuticals Announces 2017 Fourth Quarter and Year-End Results

Nuvo to Host Conference Call/Audio Webcast March 23 at 8:30 a.m. ET

March 23, 2018
·
22 min read
FDA

Smiths Medical Announces US Launch of the DeltaVen® Closed System Catheter and FDA Clearance

DeltaVen® is the next advancement in Peripheral IV Catheters.

March 23, 2018
·
1 min read